{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:28:41Z","timestamp":1784899721464,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84640-5","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T01:15:17Z","timestamp":1743124517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["LINC00894, YEATS2-AS1, and SUGP2 genes as novel biomarkers for N0 status of lung adenocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-1778","authenticated-orcid":false,"given":"Marzyeh","family":"Alipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-9399","authenticated-orcid":false,"given":"Mehdi","family":"Moghanibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6991-7309","authenticated-orcid":false,"given":"Sirous","family":"Naeimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1343-9069","authenticated-orcid":false,"given":"Parisa","family":"Mohamadynejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"1","key":"84640_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics. CA Cancer J. Clin. 72(1), 7\u201333 (2022).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"84640_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.18632\/oncotarget.13346","volume":"8","author":"M Chen","year":"2017","unstructured":"Chen, M., Liu, X., Du, J., Wang, X.-J. & Xia, L. Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers. Oncotarget 8(1), 133 (2017).","journal-title":"Oncotarget"},{"issue":"6","key":"84640_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 68(6), 394\u2013424 (2018).","journal-title":"Cancer J. Clin."},{"issue":"1","key":"84640_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1759-7714.12916","volume":"10","author":"M Cao","year":"2019","unstructured":"Cao, M. & Chen, W. Epidemiology of lung cancer in China. Thorac. Cancer 10(1), 3\u20137 (2019).","journal-title":"Thorac. cancer"},{"issue":"1","key":"84640_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. Cancer J. Clin. 68(1), 7\u201330 (2018).","journal-title":"Cancer J. Clin."},{"key":"84640_CR6","doi-asserted-by":"crossref","unstructured":"Marmor, H. N., Zorn, J. T., Deppen, S. A., Massion, P. P. & Grogan, E. L. Biomarkers in lung cancer screening: A narrative review. Curr. Challenges Thorac. Surg. 5, 1\u201313 (2023).","DOI":"10.21037\/ccts-20-171"},{"issue":"5","key":"84640_CR7","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.21037\/jtd.2019.05.20","volume":"11","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. Sublobar resection is associated with better perioperative outcomes in elderly patients with clinical stage I non-small cell lung cancer: A multicenter retrospective cohort study. J. Thorac. Disease 11(5), 1838 (2019).","journal-title":"J. Thorac. Disease"},{"issue":"2","key":"84640_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jtcvs.2017.02.065","volume":"154","author":"BA Yerokun","year":"2017","unstructured":"Yerokun, B. A. et al. A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non\u2013small cell lung cancer. J. Thorac. Cardiovasc. Surg. 154(2), 675\u2013686 (2017). e4.","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"84640_CR9","doi-asserted-by":"publisher","first-page":"644426","DOI":"10.3389\/fonc.2021.644426","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Jin, L., Jiang, Z., Liu, S. & Feng, W. Identifying and validating potential biomarkers of early stage lung adenocarcinoma diagnosis and prognosis. Front. Oncol. 11, 644426 (2021).","journal-title":"Front. Oncol."},{"issue":"4","key":"84640_CR10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2213-2600(15)00029-6","volume":"3","author":"N Navani","year":"2015","unstructured":"Navani, N. et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: An open-label, pragmatic, randomised controlled trial. Lancet Respiratory Med. 3(4), 282\u2013289 (2015).","journal-title":"Lancet Respiratory Med."},{"issue":"4","key":"84640_CR11","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1002\/ctm2.367","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Zitello, E., Guo, R. & Deng, Y. The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer. Clin. Transl. Med. 11(4), e367 (2021).","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"84640_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.21037\/qims-20-337","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. 18F-FDG PET-based radiomics model for predicting occult lymph node metastasis in clinical N0 solid lung adenocarcinoma. Quant. Imaging Med. Surg. 11(1), 215 (2021).","journal-title":"Quant. Imaging Med. Surg."},{"issue":"1","key":"84640_CR13","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1038\/s41598-023-33897-3","volume":"13","author":"K Khashei Varnamkhasti","year":"2023","unstructured":"Khashei Varnamkhasti, K., Moghanibashi, M. & Naeimi, S. Genes whose expressions in the primary lung squamous cell carcinoma are able to accurately predict the progression of metastasis through lymphatic system, inferred from a bioinformatics analyses. Sci. Rep. 13(1), 6733 (2023).","journal-title":"Sci. Rep."},{"key":"84640_CR14","doi-asserted-by":"publisher","first-page":"153551","DOI":"10.1016\/j.prp.2021.153551","volume":"224","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathol. Res. Pract. 224, 153551 (2021).","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"84640_CR15","doi-asserted-by":"publisher","first-page":"e202009045","DOI":"10.1083\/jcb.202009045","volume":"220","author":"MC Bridges","year":"2021","unstructured":"Bridges, M. C., Daulagala, A. C. & Kourtidis, A. LNCcation: lncRNA localization and function. J. Cell Biol. 220(2), e202009045 (2021).","journal-title":"J. Cell Biol."},{"issue":"1","key":"84640_CR16","first-page":"113","volume":"20","author":"Y Hu","year":"2020","unstructured":"Hu, Y., Gu, X., Duan, Y., Shen, Y. & Xie, X. Bioinformatics analysis of prognosis-related long non-coding RNAs in invasive breast carcinoma. Oncol. Lett. 20(1), 113\u2013122 (2020).","journal-title":"Oncol. Lett."},{"issue":"4","key":"84640_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.6026\/97320630014153","volume":"14","author":"Z Akond","year":"2018","unstructured":"Akond, Z., Alam, M. & Mollah, M. N. H. Biomarker identification from RNA-seq data using a robust statistical approach. Bioinformation 14(4), 153 (2018).","journal-title":"Bioinformation"},{"issue":"1","key":"84640_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1148\/radiol.2291010898","volume":"229","author":"NA Obuchowski","year":"2003","unstructured":"Obuchowski, N. A. Receiver operating characteristic curves and their use in radiology. Radiology 229(1), 3\u20138 (2003).","journal-title":"Radiology"},{"key":"84640_CR19","volume-title":"Statistical Methods in Diagnostic Medicine","author":"X-H Zhou","year":"2014","unstructured":"Zhou, X.-H., Obuchowski, N. A. & McClish, D. K. Statistical Methods in Diagnostic Medicine (Wiley, 2014)."},{"issue":"1","key":"84640_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41698-023-00456-y","volume":"7","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Implications of different cell death patterns for prognosis and immunity in lung adenocarcinoma. NPJ Precision Oncol. 7(1), 121 (2023).","journal-title":"NPJ Precision Oncol."},{"issue":"1","key":"84640_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2559.2008.03176.x","volume":"54","author":"KM Kerr","year":"2009","unstructured":"Kerr, K. M. Pulmonary adenocarcinomas: Classification and reporting. Histopathology 54(1), 12\u201327 (2009).","journal-title":"Histopathology"},{"key":"84640_CR22","doi-asserted-by":"publisher","first-page":"101364","DOI":"10.1016\/j.tranon.2022.101364","volume":"18","author":"M-J Sanaei","year":"2022","unstructured":"Sanaei, M-J., Razi, S., Pourbagheri-Sigaroodi, A. & Bashash, D. The PI3K\/Akt\/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles. Transl. Oncol. 18, 101364 (2022).","journal-title":"Transl. Oncol."},{"issue":"3","key":"84640_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/1759-7714.13328","volume":"11","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. Targeting the PI3K\/Akt\/mTOR pathway in non-small cell lung cancer (NSCLC). Thorac. Cancer 11(3), 511\u2013518 (2020).","journal-title":"Thorac. Cancer"},{"key":"84640_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.humpath.2016.12.012","volume":"62","author":"I Krencz","year":"2017","unstructured":"Krencz, I. et al. Expression of mTORC1\/2-related proteins in primary and brain metastatic lung adenocarcinoma. Hum. Pathol. 62, 66\u201373 (2017).","journal-title":"Hum. Pathol."},{"issue":"1","key":"84640_CR25","doi-asserted-by":"publisher","first-page":"e3658","DOI":"10.1002\/jgm.3658","volume":"26","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. Single-cell RNA sequencing reveals the mechanism of PI3K\/AKT\/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation. J. Gene Med. 26(1), e3658 (2024).","journal-title":"J. Gene Med."},{"issue":"1","key":"84640_CR26","first-page":"24","volume":"13","author":"S Ghareghomi","year":"2021","unstructured":"Ghareghomi, S., Atabaki, V., Abdollahzadeh, N., Ahmadian, S. & Ghoran, S. H. Bioactive PI3-kinase\/Akt\/mTOR inhibitors in targeted lung cancer therapy. Adv. Pharm. Bull. 13(1), 24 (2021).","journal-title":"Adv. Pharm. Bull."},{"issue":"04","key":"84640_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cpt.2023.04.004","volume":"1","author":"Y Yan","year":"2023","unstructured":"Yan, Y., Ren, Y., Bao, Y. & Wang, Y. RNA splicing alterations in lung cancer pathogenesis and therapy. Cancer Pathogenesis Therapy 1(04), 272\u2013283 (2023).","journal-title":"Cancer Pathogenesis Therapy"},{"issue":"1","key":"84640_CR28","doi-asserted-by":"publisher","first-page":"e30880","DOI":"10.1371\/journal.pone.0030880","volume":"7","author":"Y Lu","year":"2012","unstructured":"Lu, Y., Wang, L., Liu, P., Yang, P. & You, M. Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients. PLoS ONE 7(1), e30880 (2012).","journal-title":"PLoS ONE"},{"issue":"46","key":"84640_CR29","doi-asserted-by":"publisher","first-page":"75648","DOI":"10.18632\/oncotarget.12315","volume":"7","author":"J Zhao","year":"2016","unstructured":"Zhao, J. et al. Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in IPO11 and prognostic significance of importin-11 overexpression on poor survival. Oncotarget 7(46), 75648 (2016).","journal-title":"Oncotarget"},{"issue":"4","key":"84640_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/leu.2010.309","volume":"25","author":"V Grossmann","year":"2011","unstructured":"Grossmann, V. et al. Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure. Leukemia 25(4), 671\u2013680 (2011).","journal-title":"Leukemia"},{"issue":"1","key":"84640_CR31","first-page":"13","volume":"26","author":"J Zhong","year":"2024","unstructured":"Zhong, J. et al. Identification and functional characterization of PI3K\/Akt\/mTOR pathway-related lncRNAs in lung adenocarcinoma: A retrospective study. Cell. J. (Yakhteh) 26(1), 13 (2024).","journal-title":"Cell. J. (Yakhteh)"},{"issue":"4","key":"84640_CR32","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann, J., Piccoli, M.-T., Viereck, J. & Thum, T. Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches. Physiol. Rev. 96(4), 1297\u20131325 (2016).","journal-title":"Physiol. Rev."},{"issue":"2","key":"84640_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/onco1020014","volume":"1","author":"R Nadhan","year":"2021","unstructured":"Nadhan, R. & Dhanasekaran, D. N. Decoding the oncogenic signals from the long non-coding RNAs. Onco 1(2), 176\u2013206 (2021).","journal-title":"Onco"},{"issue":"12","key":"84640_CR34","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1089\/dna.2021.0563","volume":"40","author":"H Ghahramani Almanghadim","year":"2021","unstructured":"Ghahramani Almanghadim, H. et al. New insights into the importance of long non-coding RNAs in lung cancer: Future clinical approaches. DNA Cell Biol. 40(12), 1476\u20131494 (2021).","journal-title":"DNA Cell Biol."},{"issue":"12","key":"84640_CR35","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3390\/cancers15123135","volume":"15","author":"J Gencel-Augusto","year":"2023","unstructured":"Gencel-Augusto, J., Wu, W. & Bivona, T. G. Long non-coding RNAs as emerging targets in lung cancer. Cancers 15(12), 3135 (2023).","journal-title":"Cancers"},{"issue":"3","key":"84640_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1574892813666180226121819","volume":"13","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. & Tang, L. The application of lncRNAs in cancer treatment and diagnosis. Recent Pat. Anti-cancer Drug Discov. 13(3), 292\u2013301 (2018).","journal-title":"Recent Pat. Anti-cancer Drug Discov."},{"issue":"6","key":"84640_CR37","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/cancers13061372","volume":"13","author":"P Le","year":"2021","unstructured":"Le, P., Romano, G., Nana-Sinkam, P. & Acunzo, M. Non-coding RNAs in cancer diagnosis and therapy: Focus on lung cancer. Cancers 13(6), 1372 (2021).","journal-title":"Cancers"},{"key":"84640_CR38","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","volume":"15","author":"M Ratti","year":"2020","unstructured":"Ratti, M. et al. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: First steps from bench to bedside. Target. Oncol. 15, 261\u2013278 (2020).","journal-title":"Target. Oncol."},{"issue":"1","key":"84640_CR39","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12672-024-01189-5","volume":"15","author":"C Dai","year":"2024","unstructured":"Dai, C., Zeng, X., Zhang, X., Liu, Z. & Cheng, S. Machine learning-based integration develops a mitophagy-related lncRNA signature for predicting the progression of prostate cancer: A bioinformatic analysis. Discover Oncol. 15(1), 316 (2024).","journal-title":"Discover Oncol."},{"issue":"1","key":"84640_CR40","first-page":"1093805","volume":"2022","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. N6-Methyladenosine\u2010related lncRNAs are anticipated biomarkers for sarcoma patients. J. Oncol. 2022(1), 1093805 (2022).","journal-title":"J. Oncol."},{"issue":"1","key":"84640_CR41","doi-asserted-by":"publisher","first-page":"e24813","DOI":"10.1002\/jcla.24813","volume":"37","author":"X Zhou","year":"2023","unstructured":"Zhou, X., Zhang, H., Duan, Y., Zhu, J. & Dai, H. m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma. J. Clin. Lab. Anal. 37(1), e24813 (2023).","journal-title":"J. Clin. Lab. Anal."},{"issue":"5","key":"84640_CR42","doi-asserted-by":"publisher","first-page":"e0249951","DOI":"10.1371\/journal.pone.0249951","volume":"16","author":"P Zhang","year":"2021","unstructured":"Zhang, P., Tan, X., Zhang, D., Gong, Q. & Zhang, X. Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis. PLoS ONE 16(5), e0249951 (2021).","journal-title":"Plos One"},{"key":"84640_CR43","doi-asserted-by":"crossref","unstructured":"Huang, J. et al. LINC00894 targets annexin A2 to regulate oxaliplatin resistance in hepatocellular carcinoma: ANXA2 protein function. Int. J. Biol. Macromol. 281, 136538 (2024).","DOI":"10.1016\/j.ijbiomac.2024.136538"},{"key":"84640_CR44","doi-asserted-by":"publisher","first-page":"667610","DOI":"10.3389\/fgene.2021.667610","volume":"12","author":"L Deng","year":"2021","unstructured":"Deng, L., Wang, P., Qu, Z. & Liu, N. The construction and analysis of ceRNA network and immune infiltration in kidney renal clear cell carcinoma. Front. Genet. 12, 667610 (2021).","journal-title":"Front. Genet."},{"issue":"1","key":"84640_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12672-022-00520-2","volume":"13","author":"B Chen","year":"2022","unstructured":"Chen, B., Liu, D., Chen, R., Guo, L. & Ran, J. Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression. Discover Oncol. 13(1), 56 (2022).","journal-title":"Discover Oncol."},{"key":"84640_CR46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1134\/S0006297918050139","volume":"83","author":"X Zhang","year":"2018","unstructured":"Zhang, X., Wang, M., Sun, H., Zhu, T. & Wang, X. Downregulation of LINC00894-002 contributes to tamoxifen resistance by enhancing the TGF-\u03b2 signaling pathway. Biochemistry (Moscow) 83, 603\u2013611 (2018).","journal-title":"Biochemistry (Moscow)"},{"issue":"1","key":"84640_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12935-024-03240-5","volume":"24","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894. Cancer Cell Int. 24(1), 47 (2024).","journal-title":"Cancer Cell Int."},{"issue":"3","key":"84640_CR48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cdd.2009.195","volume":"17","author":"IKH Poon","year":"2010","unstructured":"Poon, I. K. H., Hulett, M. D. & Parish, C. R. Molecular mechanisms of late apoptotic\/necrotic cell clearance. Cell Death Differ. 17(3), 381\u2013397 (2010).","journal-title":"Cell Death Differ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84640-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84640-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84640-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T22:47:01Z","timestamp":1743374821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84640-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84640"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84640-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research protocol was approved by the Ethics Committee of the Islamic Azad University, Kazarun branch (IR.IAU.KAU.REC.1400.142). All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"By signing the consent form, the patients agreed to participate in the research and authorized the use of their samples for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"10628"}}